SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Economic Cost of Diabetes in Canada, 1998
3 references·7 citing·30 second hop
The Economic Cost of Diabetes in Canada, 1998 (2002)The Economic Cost of Diabetes in Canada, …Economic Consequences of Diabetes Mellitus in the U.S. in 1997 (1998)Economic Consequences of Diab…Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia (1997)Model of Complications of NID…Towards a new approach for estimating indirect costs of disease (1992)Towards a new approach for es…Economic burden of diabetic patients in India: A review (2019)Economic burden of diabetic p…Disease and Economic Burden of Hospitalizations Attributable to Diabetes Mellitus and Its Complications: A Nationwide Study in Brazil (2018)Disease and Economic Burden o…Direct and indirect cost of diabetes care among patients with type 2 diabetes in private clinics: a multicenter study in Punjab, Pakistan (2018)Direct and indirect cost of d…The cost of diabetes in Canada over 10 years: applying attributable health care costs to a diabetes incidence prediction model (2017)The cost of diabetes in Canad…Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico (2005)Health care costs and financi…Economic Consequences of Epidemiological Changes in Diabetes in Middle-Income Countries (2004)Economic Consequences of Epid…The cost of major comorbidity in people with diabetes mellitus. (2003)The cost of major comorbidity…Resource Needs for HIV/AIDS (2001)Economic Costs of Diabetes in the U.S. in 2002 (2003)The cost of diabetes in Latin America and the Caribbean. (2003)An average/deprivation/inequality (ADI) analysis of chronic disease outcomes and risk factors in Argentina (2009)Methods for the economic evaluation of health care programmes (1987)The friction cost method for measuring indirect costs of disease (1995)The Role of Cost-Consequence Analysis in Healthcare Decision-Making (1998)A Review of Health-Related Workplace Productivity Loss Instruments (2004)The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study (2004)Methods for the Economic Evaluation of Health Care Programmes (2005)The Economic Costs of Non—Insulin-Dependent Diabetes Mellitus (1989)Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S. (1998)Cost of medical care among type 2 diabetic patients with a co-morbid condition—Hypertension in India (2009)Density, Destinations or Both? A Comparison of Measures of Walkability in Relation to Transportation Behaviors, Obesity and Diabetes in Toronto, Canada (2014)Impact of diabetes on healthcare costs in a population‐based cohort: a cost analysis (2015)Economic Costs of Diabetes in the U.S. in 2007 (2008)Economic Costs of Diabetes in the U.S. in 2012 (2013)Administrative Data Linkage in Brazil: Potentials for Health Technology Assessment (2019)Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. (2002)Increasing Expenditure on Health Care Incurred by Diabetic Subjects in a Developing Country (2007)Economic Impact of Diabetes in South Asia: the Magnitude of the Problem (2019)Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030 (2018)An economic evaluation of diabetes mellitus in India: A systematic review (2022)Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) (2000)Health Care Economic Analyses and Value-Based Medicine (2003)Childhood predictors of late‐life diabetes: The case of Mexico (2005)Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine (2014)Revealing the cost of Type II diabetes in Europe (2002)A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) (2004)
this work references cited by second hop

References

  • 1998Economic Consequences of Diabetes Mellitus in the U.S. in 1997652 cited
  • 1997Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia333 cited
  • 1992Towards a new approach for estimating indirect costs of disease319 cited

Cited by

  • 2004Economic Consequences of Epidemiological Changes in Diabetes in Middle-Income Countries108 cited
  • 2003The cost of major comorbidity in people with diabetes mellitus.102 cited
  • 2018Disease and Economic Burden of Hospitalizations Attributable to Diabetes Mellitus and Its Complications: A Nationwide Study in Brazil89 cited
  • 2017The cost of diabetes in Canada over 10 years: applying attributable health care costs to a diabetes incidence prediction model85 cited
  • 2019Economic burden of diabetic patients in India: A review50 cited
  • 2005Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico40 cited
  • 2018Direct and indirect cost of diabetes care among patients with type 2 diabetes in private clinics: a multicenter study in Punjab, Pakistan29 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work